Co-Diagnostics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Net Income	-35.33	-14.24	36.66	42.48	-6.2	-6.27	-6.96	-1.93	-2.04
Depreciation & Amortization	1.28	1.31	0.34	0.14	0.07	0.05	0.05	0.04	0.04
Share-Based Compensation	8.34	7.54	5.51	2.74	1.09	1.33	2.03	0.07	0.06
Other Operating Activities	3.64	11.95	-1.42	-17.19	-0.48	0.81	1.67	0.51	0.41
Operating Cash Flow	-22.08	6.57	41.08	28.17	-5.53	-4.08	-3.21	-1.31	-1.53
Operating Cash Flow Growth	-	-84.01%	45.86%	-	-	-	-	-	-
Capital Expenditures	-1.37	-1.43	-0.67	-0.77	-0.11	-0.04	-0.13	-0.01	-0.12
Acquisitions	0	0	1.69	-0.71	-0.32	-0.34	-0.06	0	0
Change in Investments	16.75	-56.74	3.08	-4.34	0	0	0	0	0.01
Investing Cash Flow	15.39	-58.17	4.1	-5.82	-0.44	-0.38	-0.19	-0.01	-0.11
Share Issuance / Repurchase	-1.36	-14.03	0.45	21.2	5.5	0.03	7.07	0	0.47
Debt Issued / Paid	0	0	0	0	0	2	-0.04	2.29	0.99
Other Financing Activities	-	-	-	-1.46	0.41	-0.15	-1.09	-	-
Financing Cash Flow	-1.36	-14.03	0.45	19.74	5.9	1.88	5.94	2.29	1.46
Net Cash Flow	-8.06	-65.63	45.63	42.08	-0.06	-2.58	2.54	0.96	-0.18
Free Cash Flow	-23.45	5.14	40.41	27.39	-5.64	-4.12	-3.34	-1.32	-1.65
Free Cash Flow Growth	-	-87.28%	47.54%	-	-	-	-	-	-
Free Cash Flow Margin	-344.20%	15.02%	41.28%	36.74%	-2622.80%	-10326.41%	-43600.98%	-	-16488.36%
Free Cash Flow Per Share	-0.80	0.16	1.40	1.02	-0.34	-0.33	-0.30	-0.13	-0.18

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).